Breast Cancer News

Oncologists underestimate patient use of complementary and alternative treatments and often differ with patients in their opinions of approaches that offer benefits

A new study finds those who have adequate levels of vitamin D when diagnosed with breast cancer have better long-term outcomes.

A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report.

According to a new study, moderate use of hair relaxers doesn't increase a Black woman's risk of breast cancer.

With limited space in operating rooms, experts explore new ways to treat patients under restricted conditions.

A first-of-its-kind study suggests that slow-growing breast cancers can be treated with a highly targeted tumor-freezing technique, eliminating the need for invasive surgery.

A new study found that breast cancer survivors who are overweight have a statistically significant increased risk of developing a second primary cancer – one not connected to their previous cancer.

New findings are concerning given the widespread delays and cancellations of preventative cancer screenings that took place during early stages of the COVID-19 pandemic.

Breast cancer has surpassed lung cancer as the world's most commonly diagnosed cancer.

Women with type 2 diabetes may be more likely to develop breast cancer, but taking the diabetes drug metformin appears to reduce their risk for the most common type, new research finds.

A new study found that a majority of breast cancer patients -- 74% -- who had opted to "go flat" were satisfied with the outcome.

Obesity is a known risk factor for several types of cancer, and decades of rising rates of obesity in the United States have contributed to climbing breast cancer rates greater in Black women than white women.

The actor, known for roles in movies like Jerry Maguire and For the Love of the Game, died of breast cancer, her husband said.

A cutting-edge "lab-on-a-chip" has shown promise in detecting early breast cancers and tumors that have developed in other parts of the body.

The researchers said that as many as one in 40 postmenopausal women with breast cancer before age 65 has a mutation in the BRCA1 or BRCA2 genes.

The study found that for women with "triple-negative" breast cancer, adding Keytruda to standard chemotherapy improved their odds of responding.

Doherty, 48, first revealed she had breast cancer in 2015 and provided updates about her battle with the disease and its remission on social media, the AP reported.

The goal of dense breast notifications is to spur a conversation between a woman and her health care provider. The provider can let a woman know how having dense breast tissue affects her personal risk of breast cancer or detecting it.

In the new study, researchers found that among breast cancer patients who died five to 10 years after their diagnosis, only 38% of deaths were caused by the disease.

Aspirin's protective effect appears particularly pronounced among people who are overweight -- those with a body mass index of 25 to 29.9, the results show.

Researchers analyzed data from nearly 47,000 U.S. women, followed for an average of more than eight years as part of the federally funded Sisters Study. All of the women had a sister who'd been diagnosed with breast cancer, but they didn't have breast cancer themselves at the start of the study.

Researchers found that among 232 breast cancer patients at their hospital, those who'd undergone mammography screening every two years tended to have more advanced tumors: Of those 32 women, 44% were diagnosed with stage 2 or later cancer, versus 24% of patients who'd undergone annual screening.

Overall, higher levels of mindfulness were associated with less pain, fatigue, anxiety, depression and sleep disturbance, according to the study published Nov. 8 in the journal Psycho-Oncology.

One U.S. breast cancer expert was encouraged by the findings, but agreed there's still a long way to go before blood tests replace mammograms in breast cancer detection.

In 2017, the FDA warned health care providers and thermography device makers not to mislead people into believing thermal imaging could take the place of a mammogram.